Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Oya, Yonal"'
Autor:
Oya Yonal, Duygu Ibrisim, Yıldıran Songur, Yılmaz Cakaloglu, Koray Tuncer, Hale Kırımlıoglu, Sadakat Ozdil
Publikováno v:
Case Reports in Gastroenterology, Vol 7, Iss 2, Pp 272-276 (2013)
Primary malignant melanoma of the esophagus (PMME) comprises only 0.1-0.2% of all malignant esophageal tumors. PMME tumors are highly aggressive and metastasize early via hematogenic and lymphatic pathways. Treatment outcome is poor because the cance
Externí odkaz:
https://doaj.org/article/47beb5b31bbc4e898b7022db5e392721
Autor:
Yilmaz Cakaloglu, Duygu Ibrisim, Hale Kirimlioglu, Oya Yonal, Koray Tuncer, Yildiran Songur, Sadakat Ozdil
Publikováno v:
Case Reports in Gastroenterology, Vol 7, Iss 2, Pp 272-276 (2013)
Case Reports in Gastroenterology
Case Reports in Gastroenterology
Primary malignant melanoma of the esophagus (PMME) comprises only 0.1-0.2% of all malignant esophageal tumors. PMME tumors are highly aggressive and metastasize early via hematogenic and lymphatic pathways. Treatment outcome is poor because the cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679e26e908239d4c1c829ff71dae994b
http://www.karger.com/Article/FullText/353637
http://www.karger.com/Article/FullText/353637
Autor:
Nese Imeryuz, Ebubekir Senates, Ramazan Kurt, Yusuf Yilmaz, Oya Yonal, Fatih Eren, Mohammad Bacha, Zulfikar Polat
Publikováno v:
Clinical Biochemistry. 44:955-958
Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes.Serum leve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbcef074d746b03e891e5c1729cc672
https://doi.org/10.1016/j.clinbiochem.2011.05.015
https://doi.org/10.1016/j.clinbiochem.2011.05.015
Autor:
Ebubekir Senates, Yesim Ozen Alahdab, Nese Imeryuz, Ramazan Kurt, Huseyin Oflaz, Yusuf Yilmaz, Ahmet Gurdal, Nihat Polat, Fatih Eren, Oya Yonal
Publikováno v:
Atherosclerosis. 217:125-129
Patients with nonalcoholic fatty liver disease (NAFLD) have a reduced coronary flow reserve (CFR) and an increased risk of cardiovascular disease. The fat cells that surround coronary arteries may play a central and underrecognized role in developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e38716a52c68a8a3cbebb33e6e2b7b88
https://doi.org/10.1016/j.atherosclerosis.2011.03.026
https://doi.org/10.1016/j.atherosclerosis.2011.03.026
Autor:
Faysal Dane, Yusuf Yilmaz, Cem Kalayci, Nese Imeryuz, Oya Yonal, Ufuk Abacioglu, Beste M. Atasoy, Birsen Demirel
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 269:275-282
To investigate the impact of early insertion of percutaneous endoscopic gastrostomy-tube on nutritional status and completeness of concurrent chemotherapy in locally advanced head and neck cancer patients treated with chemoradiotherapy. Twenty-three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be78f7e2eb4b0d792bedf1ae8cacb571
https://doi.org/10.1007/s00405-010-1477-7
https://doi.org/10.1007/s00405-010-1477-7
Autor:
Ramazan Kurt, Yusuf Yilmaz, Erol Avsar, Şükran Köse, Fatih Eren, Oya Yonal, Filiz Türe Özdemir, Osman Ozdogan
Publikováno v:
Clinica Chimica Acta. 411:2029-2032
During hepatocyte apoptosis, intermediate filament protein cytokeratin 18 is cleaved by caspases at Asp396 which can be specifically detected by the monoclonal antibody M30 (M30-antigen). In this study, we sought to determine whether serum M30-antige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc291b2d12f59a608d263f04a9dd7439
https://doi.org/10.1016/j.cca.2010.08.035
https://doi.org/10.1016/j.cca.2010.08.035
Autor:
Ramazan Kurt, Yusuf Yilmaz, Cem Kalayci, Nese Imeryuz, Fatih Eren, Oya Yonal, Erol Avsar, Osman Özdoğan, Cigdem Ataizi Celikel
Publikováno v:
cclm. 49:93-97
Background: Evidence suggests that zinc-α2-glycoprotein (ZAG) might serve as a biomarker for human metabolic alterations. We measured serum ZAG in patients with non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8fd55cfba594b2017b7686dd1ceeb73
https://doi.org/10.1515/cclm.2011.022
https://doi.org/10.1515/cclm.2011.022
Autor:
Alla Eldeen Kedrah, Yesim Ozen Alahdab, Cigdem Ataizi Celikel, Nese Imeryuz, Osman Ozdogan, Cem Kalayci, Ramazan Kurt, Yusuf Yilmaz, Oya Yonal, Erol Avsar, Deniz Güney Duman
Publikováno v:
Web of Science
Recent evidence has suggested an association between microalbuminuria and ultrasound-diagnosed nonalcoholic fatty liver disease (NAFLD) in patients with diabetes and prediabetes. However, few data are available on the occurrence of microalbuminuria i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2656779e0440a5e56011b45b18bb501a
https://doi.org/10.1016/j.metabol.2009.12.012
https://doi.org/10.1016/j.metabol.2009.12.012
Autor:
Oya Yonal, Yesim Ozen Alahdab, Erol Avsar, Cem Kalayci, Osman Ozdogan, Fatih Eren, Nese Imeryuz, Ramazan Kurt, Yusuf Yilmaz, Cigdem Ataizi Celikel
Publikováno v:
Scandinavian Journal of Gastroenterology. 46:91-97
The novel adipokines omentin, chemerin, and adipsin are associated with insulin resistance and the components of the metabolic syndrome. We assayed circulating levels of these molecules and examined their association with clinical, biochemical, and h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3aa5b2fa9ca0f2bf1c42618eea3ebe
https://doi.org/10.3109/00365521.2010.516452
https://doi.org/10.3109/00365521.2010.516452
Autor:
Fatih Besisik, Atilla Ökten, Sabahattin Kaymakoglu, Filiz Akyuz, Kadir Demir, Fahriye Keskin, Zeynel Mungan, Sevgi Ciftci, Halim Issever, Sadakat Ozdil, Oya Yonal, Yilmaz Cakaloglu, Binnur Pinarbasi, Güngör Boztaş, Ahmet Uyanikoglu
Publikováno v:
Digestive Diseases and Sciences. 55:3548-3551
Levels of prohepcidin, a homeostatic regulator of iron absorption, are altered in chronic hepatitis C and liver cirrhosis. However, data on the potential alterations of prohepcidin in patients with HBV-related liver disease are scarce. We investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb066c1a94f3721a837a3c6abc56eb4
https://doi.org/10.1007/s10620-010-1183-8
https://doi.org/10.1007/s10620-010-1183-8